Research Article

Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study

Table 3

One-way ANOVA result of CD4 cells among patients living with HIV/AIDS taking IPT and ART versus ART alone in Northern Ethiopia, 2009–2017.

Exposure to IPTMean CD4 cells per cubic millimeter + SEM

BaselineUnexposed group (on ART alone)177.75 ± 3.24
Exposed group (on IPT + ART)194.14 ± 6.33
2009Unexposed group (on ART alone)186.12 ± 3.76
Exposed group (on IPT + ART)215.18 ± 6.22
2010Unexposed group (on ART alone)261.38 ± 4.77
Exposed group (on IPT + ART)306.7 ± 7.70
2011Unexposed group (on ART alone)354.33 ± 6.76
Exposed group (on IPT + ART)385.69 ± 10.61
2012Unexposed group (on ART alone)392.67 ± 6.74
Exposed group (on IPT + ART)412.66 ± 10.59
2013Unexposed group (on ART alone)442.15 ± 9.02
Exposed group (on IPT + ART)457.16 ± 11.51
2014Unexposed group (on ART alone)473.91 ± 9.78
Exposed group (on IPT + ART)498.38 ± 11.69
2015Unexposed group (on ART alone)479.97 ± 8.40
Exposed group (on IPT + ART)528.92 ± 12.54
2016Unexposed group (on ART alone)522.13 ± 9.34
Exposed group (on IPT + ART)536.84 ± 10.91
2017Exposed group (on IPT + ART)511.33 ± 9.00
Unexposed group (on ART alone)538.94 ± 11.05

Statistically significant value < 0.05; statistically significant value < 0.01. Effect of IPT on all-cause mortality and associated factors.